Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the genetic drivers of disease progression and develop innovative targeted medicines.
Since inception, we have built Character to be a patient-driven therapeutics company. Our commitment to patients comes through in the high standards we set to ensure privacy, data security, ethics, scientific rigor and meaningful impact to patient health.
We are experts from the worlds of drug discovery and development, data science, and clinical research.
